title: [Monitoring of heparins and of anticoagulants].
abstract: Anticoagulation with unfractionated heparin, low molecular weight heparin or fondaparinux is common practice in thromboembolic disease, atrial fibrillation and mechanical heart valves. Some of these molecules, with specific pharmacokinetic, requires specific monitoring. Unfractionated heparin requires close monitoring by aPTT and/or anti-FXa activity while LMWH and fondaparinux do not require biological surveillance except in a few specific situations.
authors.affiliation: Service de médecine interne générale, Département de médecine interne, de réhabilitation et gériatrie, HUG, 1211 Genève 14. Yan.Beauverd@hcuge.ch
authors.forename: Yan
authors.initials: Y
authors.lastname: Beauverd
authors.forename: Françoise
authors.initials: F
authors.lastname: Boehlen
authors.forename: Pierre
authors.initials: P
authors.lastname: Fontana
authors.forename: Martine
authors.initials: M
authors.lastname: Louis-Simonet
mesh_terms: D000925:Anticoagulants / Q000494:pharmacology*; D016903:Drug Monitoring; D006493:Heparin / Q000494:pharmacology*; D006801:Humans
chemical_list: D000925:Anticoagulants; D006493:Heparin